Navigation Links
Prosum Kicks Off Crowd Funding for Cancer Research
Date:8/9/2012

RENO, Nev., Aug. 9, 2012 /PRNewswire/ -- Prosum Breast Cancer Research, Inc. announces a Crowd Funding financing project to jump start its first research project to build the "You Will Be the Cure" for early detection breast health awareness and research. "Our first awareness project focuses on communicating individual experiences of women to educate all about the value with early detection starting at age 20," says Dave Wertzberger, Executive Director.

"We believe early detection education is much more than statistics and technology—women are the cure. The collective experience of survivors needs to be shared. We are convinced the profiles of women who have 'been there and done that' will provide invaluable awareness for women of all ages to advance the cure starting with early detection," adds Cindy Lain, Community Affairs Director.  "In addition, we see a number of early detection technologies coming to market and our goal is to confidentially involve volunteers with these technologies to improve device early detection usability and value," continues Wertzberger.

"Our Crowd Funding site at Rockethub.com provides one location to describe project goals and how individuals can support a new level of information for improving early detection and survival," says Wertzberger. "The Crowd Funding approach simplifies fund raising with contributions of $10, or more, while engaging folks wherever there is an Internet connection," says Wertzberger.

Prosum's awareness project will collect video histories as well as personal profiles in preparation for an updated web site for those who wish to share their stories to be part of our "You Will Be the Cure" awareness and research on early detection.  The fund raising goal is $30,000.  Any additional funds will be used to develop a confidential Breast Cancer History Database to improve early detection devices for positive change.

Press Ctrl, Click to follow the link Prosum Rocket Hub Link

About Prosum Breast Cancer Research

Prosum Research Foundation, Inc., dba Prosum Breast Cancer Research, (PBCR) is based in Reno, NV.  Founded in 2008, PBCR is a non-profit foundation dedicated to the dissemination of breast health information and education while advancing the state-of-the art of early detection of breast cancer to enhance current detection technologies to delivery early screening to more women by any physician.  www.prosumresearch.org 

For more information, contact: Dave Wertzberger, Executive Director 800-448-4981 dwertzberger@prosumresearch.org


'/>"/>
SOURCE Prosum Breast Cancer Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
3. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
4. BONESUPPORT Closes Second Tranche of Funding
5. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
6. Igenica Closes $33 Million in Series C Funding
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. Independa Closes Convertible Note Funding at $2.35 Million
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):